Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Godavari Drugs Ltd. Share Price
Day's Range
Day's Range
Low
₹
High
₹
Price Summary
| Previous Close | ₹105.00 |
|---|---|
| Day's Range | ₹105.00 - ₹106.55 |
| Open | ₹105.50 |
| 52 Week Range | ₹69.70 - ₹135.25 |
| Volume | 632 |
| Market Cap | ₹0.00 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 0.66 |
|---|---|
| Market Cap (₹ in Mn) | 0.00 |
| Dividend Yield(%) | 0.00 |
| Price/Earning (TTM) | 26.27 |
| TTM EPS (₹) | 4.04 |
| P/E Ratio | 15.04 |
| Book Value(₹) | 1.52 |
| PAT Margin (%) | 3.86 |
| Face Value (₹) | 10.00 |
| ROCE(%) | 10.13 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 255.03 | 1133.5 |
| Expenses | N/A | N/A |
| PBT | 14.4 | 56.25 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 8.93 | 43.8 |
About Godavari Drugs Ltd.
| Founded | 1987 |
|---|---|
| Managing Director | Mukund Kakani |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,77,311.70 | 1,968.15 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 2,13,878.74 | 8,462.00 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,94,094.11 | 5,054.00 | 3,480.60 - 3,480.60 |
| Apollo Hospitals Enterprise Ltd. | 1,28,759.16 | 8,902.05 | 6,696.50 - 6,696.50 |
| Cipla Ltd. | 1,18,992.73 | 1,468.25 | 1,165.70 - 1,165.70 |
| Zydus Lifesciences Ltd. | 1,12,368.81 | 1,124.25 | 835.50 - 835.50 |
| Lupin Ltd. | 1,10,374.22 | 2,375.15 | 1,836.80 - 1,836.80 |
| Max Healthcare Institute Ltd. | 1,06,918.95 | 1,110.65 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 1,02,005.88 | 2,474.00 | 1,909.70 - 1,909.70 |
| Laurus Labs Ltd. | 98,126.10 | 1,825.20 | 810.05 - 810.05 |
No Records Found
Latest News
Godavari Drugs informs about trading window closure
Godavari Drugs informs about secretarial compliance report
Artemis Medicare Services informs about cessation of independent director
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Artemis Medicare Services has informed that Sanjib Sen (DIN: 07088442) has ceased to be a Director of the Company upon completion of his tenure as an Independent Director on August 2, 2026. The details as required under the SEBI Listing Regulations, are provided in ‘Annexure A’.
The above information is a part of company’s filings submitted to BSE.
Park Medi World informs about investor presentation
Biocon informs about newspaper advertisement
Pursuant to Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘SEBI Listing Regulations’), Biocon has informed regarding the Commercial Launch of Yesafili™, a Biosimilar Aflibercept in the United States. The details required under Regulation 30 of the SEBI Listing Regulations read with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026, are enclosed as ‘Annexure A’. Further, Press Release titled ‘Biocon Announces U.S. Commercial Launch of Yesafili™, a Biosimilar to Regeneron’s Eylea® 2 mg’ is also enclosed as ‘Annexure B’. This intimation will also be available on website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Godavari Drugs Ltd. is ₹105.00 as of 2026-08-03.
The market capitalisation of Godavari Drugs Ltd. is ₹107.40 as of 2026-07-31.
The 1-year return of Godavari Drugs Ltd. is 22.43% as of 2025-08-01.
The P/E ratio of Godavari Drugs Ltd. is 15.04 as of 2026-08-03.
The 52-week high and low of Godavari Drugs Ltd. are ₹135.25 and ₹69.70, respectively, as of 2026-08-03.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
